- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.11. | Intercure Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 28.10. | Intercure Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 13.09. | Intercure Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| INTERCURE Aktie jetzt für 0€ handeln | |||||
| 30.08. | InterCure reports 1H results | 1 | Seeking Alpha | ||
| 30.08. | InterCure Ltd.: InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million | 742 | GlobeNewswire (Europe) | Revenues during the first half of 2024 reached NIS 126 million, alongside an Adjusted EBITDA1of NIS 21 million (Approximately 17% of revenues).Both quarters (Q1 and Q2 of 2024) ended with positive... ► Artikel lesen | |
| 28.08. | InterCure partners with Cookies to launch cannabis pharmacies in Germany | 1 | Investing.com | ||
| 28.08. | InterCure expands strategic partnership with Cookies to Germany | 1 | Seeking Alpha | ||
| 28.08. | InterCure Announces Expansion of its Strategic partnership with Cookies to Germany | 218 | Business Wire | InterCure expands its European footprint to launch Cookies Corners licensed pharmacies in Germany alongside differentiated online platforms with the official cookies retail experience, enhancing... ► Artikel lesen | |
| 28.08. | Intercure Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 01.05. | InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million | 239 | Business Wire | NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the "Company") today announced results for the full year ending December 31, 2023. All amounts... ► Artikel lesen | |
| 01.04. | InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million | 395 | Business Wire | NEW YORK & HERZLIYA, Israel--(BUSINESS WIRE)--InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) ("InterCure" or the "Company") today announced preliminary results for the full year of 2023. All amounts... ► Artikel lesen | |
| 22.03. | InterCure Ltd.: InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint | 472 | Business Wire | InterCure provides an update following recent Cannabis Reform in Germany Expects to launch its first products in Germany in the coming months The Company continues to closely watch... ► Artikel lesen | |
| 31.01. | InterCure Ltd.: InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain | 273 | GlobeNewswire (Europe) | NEW YORK, and HERZLIYA, Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), the leading medical cannabis company in Israel... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS | 9,050 | -0,55 % | Astria TherapeuticS GAAP EPS of -$0.42 in-line | ||
| ROCKET LAB USA | 19,020 | -0,63 % | Is Rocket Lab Stock a Millionaire Maker? | ||
| BOIRON | 29,700 | +1,37 % | BOIRON: EVOLUTION OF GOVERNANCE | July 3rd, 2024
The Board of Directors of Laboratoires BOIRON, meeting today under the chairmanship of Thierry BOIRON, has enacted an evolution of the Group's governance.
In this context, Thierry... ► Artikel lesen | |
| HARROW | 42,440 | 0,00 % | Pre-market Movers: California BanCorp, Harrow, Inc., Quantum Computing, BTC Digital, Calidi Biotherapeutics | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.15 A.M. ET).In the Green California BanCorp. (BCAL) is up over 33% at $23.01.
Quantum... ► Artikel lesen | |
| MEDICINOVA | 1,700 | 0,00 % | MediciNova, Inc.: MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders | LA JOLLA, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| ESSA PHARMA | 1,745 | 0,00 % | ESSA Pharma: NBC-Anlegerclub feiert schnelle +23% Rendite! | Der No Brainer Club (NBC) hat erneut sein Gespür für unterbewertete Biotech-Perlen unter Beweis gestellt. Mit ESSA Pharma konnten Mitglieder in diesem fulminanten Biotech-Herbst innerhalb weniger Tage... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,735 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Anaphylm (epinephrine) Sublingual Film pre-NDA meeting scheduled for fourth quarter 2024AQST-108 (epinephrine) Topical Gel pre-IND meeting scheduled for fourth quarter 2024Libervant® (diazepam) Buccal... ► Artikel lesen | |
| SHINECO | 2,510 | 0,00 % | SHINECO, INC. - 10-Q, Quarterly Report | ||
| CYANOTECH | 0,260 | 0,00 % | Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2025 | KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (OTCQB: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results... ► Artikel lesen | |
| REVIVA PHARMACEUTICALS | 1,220 | 0,00 % | Reviva Pharmaceuticals: Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights | - 108 patients have completed 1-year of treatment in 1-year open-label extension (OLE) trial - - Vocal biomarker speech latency data from RECOVER trial reinforce brilaroxazine's improvement on negative... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 1,120 | 0,00 % | Cumberland Pharma-Aktie erreicht 52-Wochen-Tief bei 1,07 US-Dollar | ||
| LYRA THERAPEUTICS | 0,178 | 0,00 % | Lyra Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary | ||
| OMNIAB | 3,905 | 0,00 % | OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights | EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2024, and provided operating and partner program... ► Artikel lesen | |
| BAYER | 19,450 | -0,48 % | Bayer AG Aktie: Kein Licht am Ende | Die Bayer AG erlebte am Dienstag einen massiven Einbruch an der Börse, wobei die Aktien um etwa 15% auf den niedrigsten Stand seit zwei Jahrzehnten fielen. Die enttäuschenden Quartalsergebnisse des... ► Artikel lesen | |
| MERCK KGAA | 138,35 | +0,18 % | Merck: Solide Zahlen | Merck KGaA lässt den Durchhänger nach dem Corona-Boom weiter hinter sich. Auch im vergangenen Quartal sorgte ein sich in Teilen erholendes Geschäft mit Halbleitermaterialien beim Dax-Konzern für Auftrieb... ► Artikel lesen |
Das Unternehmen INTERCURE LTD kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,380 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INTERCURE LTD finden Sie auf Wallstreet Online.
